Characterisation of Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonists in Rodent Pancreatic Beta Cells and Mice

Hypersecretion and alterations in the biological activity of the incretin hormone, glucose-dependent insulinotropic polypeptide (GIP), have been postulated as contributing factors in the development of obesity-related diabetes. However, recent studies also point to weight-reducing effects of GIP rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Perry, RA, Craig, SL, Ng, MT, Gault, VA, Flatt, PR, Irwin, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Peptide based Therapies in Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743192/
https://www.ncbi.nlm.nih.gov/pubmed/31548798
http://dx.doi.org/10.1177/1179551419875453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743192/
https://www.ncbi.nlm.nih.gov/pubmed/31548798
http://dx.doi.org/10.1177/1179551419875453

Ejemplares similares